Background: Primary cutaneous CD30(+) lymphoproliferative disorders (LPDs) includes primary cutaneous anaplastic large cell lymphoma (C-ALCL) and lymphomatoid papulosis (LyP). Though both diseases have some common clinical features the therapy and prognosis of the diseases are different. We evaluated the common and different clinical features of both diseases in our patients
